{{ currentBoardShortName }}
  • Markets
  • Indices
  • FX
  • Energy
  • Metals
Markets
As of: {{timeStamp.date}}
{{timeStamp.time}}

Markets

{{ currentBoardShortName }}
  • Markets
  • Indices
  • FX
  • Energy
  • Metals
{{data.symbol | reutersRICLabelFormat:group.RICS}}
 
{{data.netChng | number: 4 }}
{{data.netChng | number: 2 }}
{{data | displayCurrencySymbol}} {{data.price | number: 4 }}
{{data.price | number: 2 }}
{{data.symbol | reutersRICLabelFormat:group.RICS}}
 
{{data.netChng | number: 4 }}
{{data.netChng | number: 2 }}
{{data | displayCurrencySymbol}} {{data.price | number: 4 }}
{{data.price | number: 2 }}

Commodities Videos

VIDEO SIGN OUT

{{ currentStream.Name }}

{{ currentStream.Desc }}

Related Video

Continuous Play:
ON OFF

The information you requested is not available at this time, please check back again soon.

Mar 4, 2019

Pot producer Ascent granted creditor protection after licenses suspended

Cannabis sector is severely lacking medical benefit evidence: Healthcare analyst

VIDEO SIGN OUT

Security Not Found

The stock symbol {{StockChart.Ric}} does not exist

See Full Stock Page »

VANCOUVER -- Cannabis producer Ascent Industries Corp. says an order granting the company creditor protection has been issued by the Supreme Court of British Columbia.

The B.C.-based company says it filed for CCAA to address near-term liquidity issues which were in "large part" caused by Health Canada's suspension of its licences under its subsidiary Agrima Botanicals Corp.

Ascent has said that Health Canada asserts that "unauthorized activities" with cannabis took place during a period of time that it was privately held, and has suspended its producer and dealer's licence under the former Access to Cannabis for Medical Purposes Regulations regime.

Last month, Ascent said that Health Canada indicated that the company did not demonstrate that the suspension was not warranted and the government health agency still intends to revoke their licences, but it had until Feb. 20 to make additional submissions.

Agrima is still listed as suspended on Health Canada's website of licenced producers.

Ascent said today that the suspension was negatively impacting its ability to complete its strategic review to address short-term liquidity issues.

The company added that while under CCAA protection, Ascent will continue with its day to day operations and the proceedings do not include or impact the operations and activities of its other subsidiaries, including in Oregon, Nevada and Denmark.

 

Cannabis Canada is BNN Bloomberg’s in-depth series exploring the stunning formation of the entirely new – and controversial – Canadian recreational marijuana industry. Read more from the special series here and subscribe to our Cannabis Canada newsletter to have the latest marijuana news delivered directly to your inbox every day.

Editor's note: This is a corrected story. A previous version stated that Ascent's licences had been revoked.